Sort
82,697 grants matching “vaccine development”
Center for Viral Systems Biology (CViSB)
$2,568,706Kristian Graugaard Andersen · Scripps Research Institute, The · U19 · FY2025 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,568,667Andrea L Cox · Johns Hopkins University · U19 · FY2025 · AI
Units for HIV/AIDS Clinical Trials Networks
$2,568,528Richard C. Reichman · University Of Rochester · U01 · FY2007 · AI
Core E: Phylogenetic and mutational scanning
$2,568,140Jesse D Bloom · University Of Washington · U19 · FY2024 · AI
Design Of Immunogens
$2,567,806Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Northwestern University Clinical Trial Unit
$2,566,649Robert L. Murphy · Northwestern University At Chicago · U01 · FY2008 · AI
BSL4 Evaluation Core
$2,566,443Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2018 · AI
Centers for AIDS Research (CFAR)
$2,566,369Kent J. Weinhold · Duke University · P30 · FY2020 · AI
Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Inf
$2,565,880Cosette Marie Wheeler · University Of New Mexico Health Scis Ctr · U19 · FY2017 · AI
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models
$2,565,790Colleen B Jonsson · University Of Tennessee Health Sci Ctr · U19 · FY2021 · AI
Defining and Exploiting a Genetic Template for an HIV Vaccine
$2,565,000Daniel Lingwood · Massachusetts General Hospital · DP2 · FY2016 · DA
Clinical Studies of Vaccines for Pandemic Influenza
$2,564,575Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Translational Immunology Research and Accelerated [vaccine] Development (TRIAD)
$2,564,398Anne Searls De Groot · University Of Rhode Island · U19 · FY2010 · AI
Sexually Transmitted Infections Clinical Trials Group
$2,564,303Giudice Linda · University Of California, San Francisco · N01 · FY2017 · AI
Optimizing malaria transmission-blocking vaccines with improved platforms
$2,563,513Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Southeastern Sexually Transmitted Infections Cooperative Research Center
$2,563,171Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U19 · FY2009 · AI
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$2,562,752Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Development of an Anthrax Vaccine
$2,562,540Sukjoon Park · Emergent Product Development Gaithersbur · N01 · FY2021 · AI
Cancer Center Support Grant
$2,562,428Gerold Bepler · Wayne State University · P30 · FY2020 · CA
Cancer Center Support Grant
$2,562,428Gerold Bepler · Wayne State University · P30 · FY2019 · CA
Cancer Center Support Grant
$2,562,428Gerold Bepler · Wayne State University · P30 · FY2018 · CA
Cancer Center Support Grant
$2,562,428Gerold Bepler · Wayne State University · P30 · FY2017 · CA
Therapeutic Monoclonal Antibodies to H5N1 Influenza
$2,562,311Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2009 · AI
SPORE in Brain Cancer
$2,562,260Darell D Bigner · Duke University · P50 · FY2006 · CA
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$2,561,973Pamela J Bjorkman · California Institute Of Technology · P01 · FY2019 · AI